Form 4 Filing for ARTELO BIOSCIENCES, INC.

This filing details a Form 4 filed by Kelly Steven, a director at ARTELO BIOSCIENCES, INC. (ARTL), on July 21, 2026. The report covers transactions on July 17, 2026, specifically the acquisition of 136 shares through a stock option. The option, with an exercise price of $1.15, is set to vest on the earlier of the one-year anniversary of the Vesting Commencement Date (July 17, 2026) or the day prior to the next annual stockholders' meeting, provided Steven remains a Service Provider. The option expires on July 17, 2036. Steven acquired these shares indirectly, with a post-transaction ownership of 136 shares.